Correlation Between Biofil Chemicals and 63 Moons

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biofil Chemicals and 63 Moons at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofil Chemicals and 63 Moons into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biofil Chemicals Pharmaceuticals and 63 moons technologies, you can compare the effects of market volatilities on Biofil Chemicals and 63 Moons and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofil Chemicals with a short position of 63 Moons. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofil Chemicals and 63 Moons.

Diversification Opportunities for Biofil Chemicals and 63 Moons

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Biofil and 63MOONS is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Biofil Chemicals Pharmaceutica and 63 moons technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 63 moons technologies and Biofil Chemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofil Chemicals Pharmaceuticals are associated (or correlated) with 63 Moons. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 63 moons technologies has no effect on the direction of Biofil Chemicals i.e., Biofil Chemicals and 63 Moons go up and down completely randomly.

Pair Corralation between Biofil Chemicals and 63 Moons

Assuming the 90 days trading horizon Biofil Chemicals is expected to generate 17.65 times less return on investment than 63 Moons. In addition to that, Biofil Chemicals is 1.01 times more volatile than 63 moons technologies. It trades about 0.01 of its total potential returns per unit of risk. 63 moons technologies is currently generating about 0.26 per unit of volatility. If you would invest  35,850  in 63 moons technologies on September 3, 2024 and sell it today you would earn a total of  30,455  from holding 63 moons technologies or generate 84.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Biofil Chemicals Pharmaceutica  vs.  63 moons technologies

 Performance 
       Timeline  
Biofil Chemicals Pha 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Biofil Chemicals Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical indicators, Biofil Chemicals is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
63 moons technologies 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in 63 moons technologies are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, 63 Moons unveiled solid returns over the last few months and may actually be approaching a breakup point.

Biofil Chemicals and 63 Moons Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biofil Chemicals and 63 Moons

The main advantage of trading using opposite Biofil Chemicals and 63 Moons positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofil Chemicals position performs unexpectedly, 63 Moons can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 63 Moons will offset losses from the drop in 63 Moons' long position.
The idea behind Biofil Chemicals Pharmaceuticals and 63 moons technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
CEOs Directory
Screen CEOs from public companies around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated